Dr. Bayan Alhaddad, Ms. Eileen Kasperek, Dr. Jill M Kramer
{"title":"IL-36 家族细胞因子诱导原发性 Sjogren 病的免疫激活","authors":"Dr. Bayan Alhaddad, Ms. Eileen Kasperek, Dr. Jill M Kramer","doi":"10.1016/j.oooo.2024.04.017","DOIUrl":null,"url":null,"abstract":"<div><p>Primary Sjogren's disease (pSD) is a chronic autoimmune disease. Patients often experience dry eyes and mouth in addition to extra-glandular manifestations. In pSD, underlying disease mechanisms remain poorly understood and no curative therapies are available. Myd88 is a cytosolic adapter molecule that is utilized by both innate and adaptive immunity. While Myd88 is required for pSD pathogenesis, the mediators of Myd88 activation are not well understood in this disease. IL-36 family cytokines (IL-36a, IL-36b, and IL-36g) rely on Myd88 for signaling. These cytokines mediate inflammation in other autoimmune diseases, but the role of these cytokines in pSD is unknown. Our objective was to investigate the role of IL-36 cytokines in pSD using a mouse model and patient samples. We isolated spleens from pSD mice and healthy controls. Splenocytes were cultured overnight in media alone, or media containing IL-36α, IL-36β, or IL36γ. Cells and supernatants were harvested and flow cytometry, ELISAs, and cytokine multiplex arrays were performed. In addition, we performed ELISAs on sera from pSD patients and controls to quantify levels of IL-36α, IL-36β, and IL36γ. Our results revealed that IL-36 family cytokines induced elevated expression of the activation markers CD69 and CD86 in B cells from pSD mice as compared to those from controls. Moreover, the pro-inflammatory cytokines IFNγ, IL-1α, IL-1β, IL-6, IL-12 p70 and GM-CSF were increased in pSD splenocyte cultures following stimulation with IL-36 family cytokines as compared to those from controls. Finally, sera from pSD patients displayed elevated levels of IL-36α and IL36γ as compared to non-pSD controls. In conclusion, our study shows that IL-36 family cytokines can induce heightened immune activation in the context of pSD and pSD patients have elevated levels of IL-36 family cytokines in sera. Thus, targeting of IL-36 signaling networks may represent a novel therapeutic strategy for patients with pSD.</p></div>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":"138 2","pages":"Page e33"},"PeriodicalIF":2.0000,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IL-36 family cytokines induce immune activation in primary Sjogren's disease\",\"authors\":\"Dr. Bayan Alhaddad, Ms. Eileen Kasperek, Dr. Jill M Kramer\",\"doi\":\"10.1016/j.oooo.2024.04.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Primary Sjogren's disease (pSD) is a chronic autoimmune disease. Patients often experience dry eyes and mouth in addition to extra-glandular manifestations. In pSD, underlying disease mechanisms remain poorly understood and no curative therapies are available. Myd88 is a cytosolic adapter molecule that is utilized by both innate and adaptive immunity. While Myd88 is required for pSD pathogenesis, the mediators of Myd88 activation are not well understood in this disease. IL-36 family cytokines (IL-36a, IL-36b, and IL-36g) rely on Myd88 for signaling. These cytokines mediate inflammation in other autoimmune diseases, but the role of these cytokines in pSD is unknown. Our objective was to investigate the role of IL-36 cytokines in pSD using a mouse model and patient samples. We isolated spleens from pSD mice and healthy controls. Splenocytes were cultured overnight in media alone, or media containing IL-36α, IL-36β, or IL36γ. Cells and supernatants were harvested and flow cytometry, ELISAs, and cytokine multiplex arrays were performed. In addition, we performed ELISAs on sera from pSD patients and controls to quantify levels of IL-36α, IL-36β, and IL36γ. Our results revealed that IL-36 family cytokines induced elevated expression of the activation markers CD69 and CD86 in B cells from pSD mice as compared to those from controls. Moreover, the pro-inflammatory cytokines IFNγ, IL-1α, IL-1β, IL-6, IL-12 p70 and GM-CSF were increased in pSD splenocyte cultures following stimulation with IL-36 family cytokines as compared to those from controls. Finally, sera from pSD patients displayed elevated levels of IL-36α and IL36γ as compared to non-pSD controls. In conclusion, our study shows that IL-36 family cytokines can induce heightened immune activation in the context of pSD and pSD patients have elevated levels of IL-36 family cytokines in sera. Thus, targeting of IL-36 signaling networks may represent a novel therapeutic strategy for patients with pSD.</p></div>\",\"PeriodicalId\":49010,\"journal\":{\"name\":\"Oral Surgery Oral Medicine Oral Pathology Oral Radiology\",\"volume\":\"138 2\",\"pages\":\"Page e33\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Surgery Oral Medicine Oral Pathology Oral Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212440324001949\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212440324001949","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
IL-36 family cytokines induce immune activation in primary Sjogren's disease
Primary Sjogren's disease (pSD) is a chronic autoimmune disease. Patients often experience dry eyes and mouth in addition to extra-glandular manifestations. In pSD, underlying disease mechanisms remain poorly understood and no curative therapies are available. Myd88 is a cytosolic adapter molecule that is utilized by both innate and adaptive immunity. While Myd88 is required for pSD pathogenesis, the mediators of Myd88 activation are not well understood in this disease. IL-36 family cytokines (IL-36a, IL-36b, and IL-36g) rely on Myd88 for signaling. These cytokines mediate inflammation in other autoimmune diseases, but the role of these cytokines in pSD is unknown. Our objective was to investigate the role of IL-36 cytokines in pSD using a mouse model and patient samples. We isolated spleens from pSD mice and healthy controls. Splenocytes were cultured overnight in media alone, or media containing IL-36α, IL-36β, or IL36γ. Cells and supernatants were harvested and flow cytometry, ELISAs, and cytokine multiplex arrays were performed. In addition, we performed ELISAs on sera from pSD patients and controls to quantify levels of IL-36α, IL-36β, and IL36γ. Our results revealed that IL-36 family cytokines induced elevated expression of the activation markers CD69 and CD86 in B cells from pSD mice as compared to those from controls. Moreover, the pro-inflammatory cytokines IFNγ, IL-1α, IL-1β, IL-6, IL-12 p70 and GM-CSF were increased in pSD splenocyte cultures following stimulation with IL-36 family cytokines as compared to those from controls. Finally, sera from pSD patients displayed elevated levels of IL-36α and IL36γ as compared to non-pSD controls. In conclusion, our study shows that IL-36 family cytokines can induce heightened immune activation in the context of pSD and pSD patients have elevated levels of IL-36 family cytokines in sera. Thus, targeting of IL-36 signaling networks may represent a novel therapeutic strategy for patients with pSD.
期刊介绍:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology is required reading for anyone in the fields of oral surgery, oral medicine, oral pathology, oral radiology or advanced general practice dentistry. It is the only major dental journal that provides a practical and complete overview of the medical and surgical techniques of dental practice in four areas. Topics covered include such current issues as dental implants, treatment of HIV-infected patients, and evaluation and treatment of TMJ disorders. The official publication for nine societies, the Journal is recommended for initial purchase in the Brandon Hill study, Selected List of Books and Journals for the Small Medical Library.